scutellarin has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksit, D; Aksit, H; Altun, E | 1 |
| Chen, L; Liu, M; Meng, X; Ren, S; Sun, Q; Xu, H; Yang, H; Zeng, S; Zhao, H | 1 |
2 other study(ies) available for scutellarin and Colitis Gravis
| Article | Year |
|---|---|
Protective effects of scutellarin in experimental colitis in rats.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Colitis; Colitis, Ulcerative; Interleukin-6; Male; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
Scutellarin ameliorates colitis-associated colorectal cancer by suppressing Wnt/β-catenin signaling cascade.
Topics: Animals; Apigenin; Azoxymethane; Carcinogenesis; Colitis-Associated Neoplasms; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Glucuronates; HT29 Cells; Humans; Male; Mice; Wnt Signaling Pathway | 2021 |